Value Evidence, Pricing and Pipeline Access Therapeutic Area Lead, I2

At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections,  where you are valued, accepted and respected for who you are, allowing you to thrive both personally and professionally. This is how we aim to prevent, stop and cure diseases and ensure everyone has access to healthcare today and for generations to come. Join Roche, where every voice matters.

The Position

Ÿ   Principle Roles & Responsibilities / Accountabilities 主要职责/责任

(Major functions of the position)  （职位的首要职能）

1. Pricing Strategy & Lifecycle Governance / 定价策略与生命周期治理

·   Price-Volume & Analytics / 价格分析与洞察: Lead team to conduct price-volume and other relevant in-depth analysis, and lead external research if needed to advance understanding on access dynamics and pricing insights.

·   Lifecycle Pricing / 全生命周期价格策略: Develop pricing and financing proposals including PAP/PBP schemes for new product launch, national and local reimbursement listing, national volume-based purchasing (VBP), and other pricing-related events throughout the product’s lifecycle.

·   Business Plan Integration / 业务规划整合: Lead team to ensure that China product pricing is effectively integrated into business plans.

·   Pricing Governance & PC Management / 价格管理: Oversee company’s pricing governance for assigned TA and lead team to coordinate the planning of Roche China Pricing Committee (PC) meetings to review designated pricing topics.

·   Global Alignment & Endorsement / 总部沟通与对齐: Facilitate global pricing and management’s endorsement and concurrence on China proposals; ensure China pricing perspective is incorporated into respective global product pricing strategy via close correspondence with relevant global access pricing teams.

·   Pricing implementation / 定价策略执行: Work with cross-functional teams to ensure endorsed pricing strategies' implementation.

2. HE/HTA & Value Evidence Generation / 卫生经济学、HTA 与价值证据生成

·   Design Value Proposition / 价值主张设计: Design key products value proposition based on collaboration and alignment with cross-functional colleagues including business units, strategic planning, medical affairs, and global access functions serving Roche China market priorities.

·   HEOR & Outcomes Studies / 卫生经济学与结果研究: Oversee the design and implementation of relevant health economics and outcomes studies, including disease burden study, CEA, BIA and epidemiological analyses if needed, or leverage RWD, to generate necessary evidence aligned with value proposition.

·   RWD & Payer-Driven Evidence Generation / 基于 RWD 与医保数据的证据产出: Drive RWD-based evidence generation, particularly leveraging healthcare and medical insurance claim database insights, to address key questions and priorities from payers and policy makers, while empowering compelling brand value narratives.

·   Milestone Alignment & Business Support / 节点对齐与商业准入支持: The evidence generation should meet the product launch, and pricing and reimbursement timeline to support product commercial and access objectives.

3. Pipeline Access & Early Value Readiness / 管线准入与早期价值准备

·   Primary Contact & Early Input / 准入核心接口与早期输入: Serve as the primary contact for the access team at the pipeline stage across local cross-functional teams (e.g., Commercial, Medical, Regulatory) and between Global and China. Lead the team to develop pipeline pricing strategies, provide inputs into early trial designs and integrated evidence plans, formulate long-term pipeline value strategies, and collaborate on clinical trial investment decision recommendations.

·   Early Strategy Readiness / 早期策略准备: Ensure early access strategy readiness (encompassing pricing, value evidence, and policy) for strategic pipelines to maximize asset value post-launch. This involves developing product briefings, access profiling, and market positioning based on potential China market barriers and opportunities; conducting horizon scanning for policy changes and emerging payer trends; preparing reimbursement value position drafts and identifying Key Success Factors (KSFs) prior to approval; and facilitating pilot policy-shaping initiatives where necessary.

·   Cross-Functional & Regulatory Alignment / 研发注册与商业策略联动: Liaison closely with China PD, regulatory, and launch squads to ensure post-launch access needs and considerations are effectively integrated into clinical development and regulatory decisions (including label descriptions); align key commercial messages and pre-launch/launch initiatives with defined reimbursement and access value positions.

4. Integrated Value Access Solutions, Global Alignment & Ecosystem Shaping / 多职能整合的价值准入解决方案、总部对齐与生态塑造

·   End-to-End Value Access Framework / 端到端整合准入体系: Integrate HTA evidence, pipeline access insights, and pricing frameworks into a cohesive, end-to-end value access system ("value argumentation - evidence support - value premium") tailored for TA products across their lifecycle and key access milestones, e.g., NRDL, Commercial Health Insurance (CHI/Catalogue C), and innovative payment models.

·   Value Philosophy & Global Strategic Influence / 价值理念树立与全球战略影响: Build up company philosophy of value-based pricing and evidence-driven market access strategy. Establish and maintain robust communication channels with global access, to represent China's needs and influence the global team for critical access decisions.

·   Stakeholder Partnerships & Ecosystem Shaping / 利益相关方合作与外部生态塑造: Build strong partnerships with internal and external stakeholders to shape a reliable and sustainable innovation-rewarding, value-recognizing pricing environment and HTA ecosystem through amplifying the value impact.

5. Team Leadership & Capability Development / 团队领导与能力建设

·   Cross-Functional Line Management / 跨功能团队直接管理: Directly manage, guide, and empower a multi-functional team of HTA/HE and Pricing/Pipeline Access managers/specialists within the assigned TA. Foster team alignment to maximize the "value-pricing synergistic effect" in an agile team structure.

Talent Coaching & Capability Building / 人才赋能与梯队建设: Coach and mentor team members in health economics modeling, pricing algorithms, early pipeline evaluation, and cross-cultural matrix communication to build a high-performing talent pipeline.

 

 

Who we are

A healthier future drives us to innovate. Together, more than 100’000 employees across the globe are dedicated to advance science, ensuring everyone has access to healthcare today and for generations to come. Our efforts result in more than 26 million people treated with our medicines and over 30 billion tests conducted using our Diagnostics products. We empower each other to explore new possibilities, foster creativity, and keep our ambitions high, so we can deliver life-changing healthcare solutions that make a global impact.

Let’s build a healthier future, together.

Roche is an Equal Opportunity Employer.